1 Market Overview

1.1 Product Overview and Scope of Transient Receptor Potential Cation Channel Subfamily V Member 1

1.2 Classification of Transient Receptor Potential Cation Channel Subfamily V Member 1 by Type

1.2.1 Overview: Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type in 2020

1.2.3 CMX-020

1.2.4 CA-016

1.2.5 DD-04107

1.2.6 Others

1.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Application

1.3.1 Overview: Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Ophthalmology

1.3.3 Immunology

1.3.4 Muscle Spasm

1.3.5 Pruritus

1.3.6 Abdominal Pain

1.3.7 Others

1.4 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size & Forecast

1.5 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast by Region

1.5.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region, (2016-2021)

1.5.3 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Prospect (2016-2026)

1.5.4 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Prospect (2016-2026)

1.5.6 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Drivers

1.6.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Restraints

1.6.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Trends Analysis

2 Company Profiles

2.1 Amgen Inc

2.1.1 Amgen Inc Details

2.1.2 Amgen Inc Major Business

2.1.3 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

2.1.4 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Amgen Inc Recent Developments and Future Plans

2.2 Amorepacific Corp

2.2.1 Amorepacific Corp Details

2.2.2 Amorepacific Corp Major Business

2.2.3 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

2.2.4 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Amorepacific Corp Recent Developments and Future Plans

2.3 BCN Peptides SA

2.3.1 BCN Peptides SA Details

2.3.2 BCN Peptides SA Major Business

2.3.3 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

2.3.4 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 BCN Peptides SA Recent Developments and Future Plans

2.4 Centrexion Therapeutics Corp

2.4.1 Centrexion Therapeutics Corp Details

2.4.2 Centrexion Therapeutics Corp Major Business

2.4.3 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

2.4.4 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Centrexion Therapeutics Corp Recent Developments and Future Plans

2.5 Daewoong Pharmaceutical Co Ltd

2.5.1 Daewoong Pharmaceutical Co Ltd Details

2.5.2 Daewoong Pharmaceutical Co Ltd Major Business

2.5.3 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

2.5.4 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Daewoong Pharmaceutical Co Ltd Recent Developments and Future Plans

2.6 DoNatur GmbH

2.6.1 DoNatur GmbH Details

2.6.2 DoNatur GmbH Major Business

2.6.3 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

2.6.4 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 DoNatur GmbH Recent Developments and Future Plans

2.7 Flex Pharma Inc

2.7.1 Flex Pharma Inc Details

2.7.2 Flex Pharma Inc Major Business

2.7.3 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

2.7.4 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Flex Pharma Inc Recent Developments and Future Plans

2.8 Grunenthal GmbH

2.8.1 Grunenthal GmbH Details

2.8.2 Grunenthal GmbH Major Business

2.8.3 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

2.8.4 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Grunenthal GmbH Recent Developments and Future Plans

2.9 Kyowa Hakko Kirin Co Ltd

2.9.1 Kyowa Hakko Kirin Co Ltd Details

2.9.2 Kyowa Hakko Kirin Co Ltd Major Business

2.9.3 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

2.9.4 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Kyowa Hakko Kirin Co Ltd Recent Developments and Future Plans

2.10 Medifron DBT Co Ltd

2.10.1 Medifron DBT Co Ltd Details

2.10.2 Medifron DBT Co Ltd Major Business

2.10.3 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

2.10.4 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Medifron DBT Co Ltd Recent Developments and Future Plans

2.11 Neurim Pharmaceuticals Ltd

2.11.1 Neurim Pharmaceuticals Ltd Details

2.11.2 Neurim Pharmaceuticals Ltd Major Business

2.11.3 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

2.11.4 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Neurim Pharmaceuticals Ltd Recent Developments and Future Plans

2.12 Pila Pharma AB

2.12.1 Pila Pharma AB Details

2.12.2 Pila Pharma AB Major Business

2.12.3 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

2.12.4 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Pila Pharma AB Recent Developments and Future Plans

2.13 Sylentis SAU

2.13.1 Sylentis SAU Details

2.13.2 Sylentis SAU Major Business

2.13.3 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

2.13.4 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Sylentis SAU Recent Developments and Future Plans

2.14 Toray Industries Inc

2.14.1 Toray Industries Inc Details

2.14.2 Toray Industries Inc Major Business

2.14.3 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

2.14.4 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Toray Industries Inc Recent Developments and Future Plans

2.15 Vitality Biopharma Inc

2.15.1 Vitality Biopharma Inc Details

2.15.2 Vitality Biopharma Inc Major Business

2.15.3 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

2.15.4 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Vitality Biopharma Inc Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Players Market Share

3.2.2 Top 10 Transient Receptor Potential Cation Channel Subfamily V Member 1 Players Market Share

3.2.3 Market Competition Trend

3.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Market Share by Type (2016-2021)

4.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2016-2021)

5.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2016-2026)

6.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2016-2026)

6.3 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country

6.3.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2016-2026)

6.3.2 United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast (2016-2026)

6.3.3 Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast (2016-2026)

6.3.4 Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2016-2026)

7.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2016-2026)

7.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country

7.3.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2016-2026)

7.3.2 Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast (2016-2026)

7.3.3 France Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast (2016-2026)

7.3.5 Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast (2016-2026)

7.3.6 Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2016-2026)

8.2 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2016-2026)

8.3 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region

8.3.1 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Region (2016-2026)

8.3.2 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast (2016-2026)

8.3.3 Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast (2016-2026)

8.3.4 South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast (2016-2026)

8.3.5 India Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast (2016-2026)

8.3.7 Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2016-2026)

9.2 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2016-2026)

9.3 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country

9.3.1 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2016-2026)

9.3.2 Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast (2016-2026)

9.3.3 Argentina Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2016-2026)

10.2 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2016-2026)

10.3 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country

10.3.1 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2016-2026)

10.3.2 Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast (2016-2026)

10.3.4 UAE Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million) by Region (2016-2021)

Table 5. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Region (2021-2026)

Table 6. Amgen Inc Corporate Information, Head Office, and Major Competitors

Table 7. Amgen Inc Major Business

Table 8. Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

Table 9. Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Amorepacific Corp Corporate Information, Head Office, and Major Competitors

Table 11. Amorepacific Corp Major Business

Table 12. Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

Table 13. Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. BCN Peptides SA Corporate Information, Head Office, and Major Competitors

Table 15. BCN Peptides SA Major Business

Table 16. BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

Table 17. BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Centrexion Therapeutics Corp Corporate Information, Head Office, and Major Competitors

Table 19. Centrexion Therapeutics Corp Major Business

Table 20. Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

Table 21. Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Daewoong Pharmaceutical Co Ltd Corporate Information, Head Office, and Major Competitors

Table 23. Daewoong Pharmaceutical Co Ltd Major Business

Table 24. Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

Table 25. Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. DoNatur GmbH Corporate Information, Head Office, and Major Competitors

Table 27. DoNatur GmbH Major Business

Table 28. DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

Table 29. DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Flex Pharma Inc Corporate Information, Head Office, and Major Competitors

Table 31. Flex Pharma Inc Major Business

Table 32. Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

Table 33. Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Grunenthal GmbH Corporate Information, Head Office, and Major Competitors

Table 35. Grunenthal GmbH Major Business

Table 36. Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

Table 37. Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Kyowa Hakko Kirin Co Ltd Corporate Information, Head Office, and Major Competitors

Table 39. Kyowa Hakko Kirin Co Ltd Major Business

Table 40. Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

Table 41. Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Medifron DBT Co Ltd Corporate Information, Head Office, and Major Competitors

Table 43. Medifron DBT Co Ltd Major Business

Table 44. Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

Table 45. Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Neurim Pharmaceuticals Ltd Corporate Information, Head Office, and Major Competitors

Table 47. Neurim Pharmaceuticals Ltd Major Business

Table 48. Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

Table 49. Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Pila Pharma AB Corporate Information, Head Office, and Major Competitors

Table 51. Pila Pharma AB Major Business

Table 52. Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

Table 53. Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Sylentis SAU Corporate Information, Head Office, and Major Competitors

Table 55. Sylentis SAU Major Business

Table 56. Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

Table 57. Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Toray Industries Inc Corporate Information, Head Office, and Major Competitors

Table 59. Toray Industries Inc Major Business

Table 60. Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

Table 61. Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Vitality Biopharma Inc Corporate Information, Head Office, and Major Competitors

Table 63. Vitality Biopharma Inc Major Business

Table 64. Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Solutions

Table 65. Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million) by Players (2019-2021)

Table 67. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Players (2019-2021)

Table 68. Breakdown of Transient Receptor Potential Cation Channel Subfamily V Member 1 by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Transient Receptor Potential Cation Channel Subfamily V Member 1 Players Head Office, Products and Services Provided

Table 70. Transient Receptor Potential Cation Channel Subfamily V Member 1 Mergers & Acquisitions in the Past Five Years

Table 71. Transient Receptor Potential Cation Channel Subfamily V Member 1 New Entrants and Expansion Plans

Table 72. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million) by Type (2016-2021)

Table 73. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Type (2016-2021)

Table 74. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Forecast by Type (2021-2026)

Table 75. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2016-2021)

Table 76. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Forecast by Application (2021-2026)

Table 77. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2016-2021) & (USD Million)

Table 78. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2026) & (USD Million)

Table 79. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2016-2021) & (USD Million)

Table 80. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2026) & (USD Million)

Table 81. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2016-2021) & (USD Million)

Table 82. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2021-2026) & (USD Million)

Table 83. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2016-2021) & (USD Million)

Table 84. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2026) & (USD Million)

Table 85. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2016-2021) & (USD Million)

Table 86. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2026) & (USD Million)

Table 87. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2016-2021) & (USD Million)

Table 88. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2021-2026) & (USD Million)

Table 89. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2016-2021) & (USD Million)

Table 90. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2026) & (USD Million)

Table 91. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2016-2021) & (USD Million)

Table 92. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2026) & (USD Million)

Table 93. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Region (2016-2021) & (USD Million)

Table 94. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Region (2021-2026) & (USD Million)

Table 95. South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2016-2021) & (USD Million)

Table 96. South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2026) & (USD Million)

Table 97. South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2016-2021) & (USD Million)

Table 98. South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2026) & (USD Million)

Table 99. South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2016-2021) & (USD Million)

Table 100. South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2021-2026) & (USD Million)

Table 101. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2016-2021) & (USD Million)

Table 102. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2026) & (USD Million)

Table 103. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2016-2021) & (USD Million)

Table 104. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2026) & (USD Million)

Table 105. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2016-2021) & (USD Million)

Table 106. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Transient Receptor Potential Cation Channel Subfamily V Member 1 Picture

Figure 2. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type in 2020

Figure 3. CMX-020

Figure 4. CA-016

Figure 5. DD-04107

Figure 6. Others

Figure 7. Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application in 2020

Figure 8. Ophthalmology Picture

Figure 9. Immunology Picture

Figure 10. Muscle Spasm Picture

Figure 11. Pruritus Picture

Figure 12. Abdominal Pain Picture

Figure 13. Others Picture

Figure 14. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 15. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Forecast (2016-2026) & (USD Million)

Figure 16. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Region (2016-2026)

Figure 17. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Region in 2020

Figure 18. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Drivers

Figure 24. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Restraints

Figure 25. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Trends

Figure 26. Amgen Inc Recent Developments and Future Plans

Figure 27. Amorepacific Corp Recent Developments and Future Plans

Figure 28. BCN Peptides SA Recent Developments and Future Plans

Figure 29. Centrexion Therapeutics Corp Recent Developments and Future Plans

Figure 30. Daewoong Pharmaceutical Co Ltd Recent Developments and Future Plans

Figure 31. DoNatur GmbH Recent Developments and Future Plans

Figure 32. Flex Pharma Inc Recent Developments and Future Plans

Figure 33. Grunenthal GmbH Recent Developments and Future Plans

Figure 34. Kyowa Hakko Kirin Co Ltd Recent Developments and Future Plans

Figure 35. Medifron DBT Co Ltd Recent Developments and Future Plans

Figure 36. Neurim Pharmaceuticals Ltd Recent Developments and Future Plans

Figure 37. Pila Pharma AB Recent Developments and Future Plans

Figure 38. Sylentis SAU Recent Developments and Future Plans

Figure 39. Toray Industries Inc Recent Developments and Future Plans

Figure 40. Vitality Biopharma Inc Recent Developments and Future Plans

Figure 41. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Players in 2020

Figure 42. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 43. Global Top 3 Players Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share in 2020

Figure 44. Global Top 10 Players Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share in 2020

Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 46. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Type in 2020

Figure 47. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share Forecast by Type (2021-2026)

Figure 48. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Application in 2020

Figure 49. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share Forecast by Application (2021-2026)

Figure 50. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Market Share by Type (2016-2026)

Figure 51. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Market Share by Application (2016-2026)

Figure 52. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Country (2016-2026)

Figure 53. United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Market Share by Type (2016-2026)

Figure 57. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Market Share by Application (2016-2026)

Figure 58. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Country (2016-2026)

Figure 59. Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. France Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. United Kingdom Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Market Share by Type (2016-2026)

Figure 65. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Market Share by Application (2016-2026)

Figure 66. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Region (2016-2026)

Figure 67. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. India Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Southeast Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Market Share by Type (2016-2026)

Figure 74. South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Market Share by Application (2016-2026)

Figure 75. South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Country (2016-2026)

Figure 76. Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Argentina Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Market Share by Type (2016-2026)

Figure 79. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Market Share by Application (2016-2026)

Figure 80. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Country (2016-2026)

Figure 81. Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Saudi Arabia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. UAE Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. Methodology

Figure 85. Research Process and Data Source